Neurocrine Biosciences Inc. (NBIX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Neurocrine Biosciences In...

    NASDAQ: NBIX · Real-Time Price · USD
    137.03
    0.29 (0.21%)
    At close: Oct 03, 2025, 3:59 PM
    137.03
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Neurocrine Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 233M 251.1M 262.9M 340.8M
    Short-Term Investments
    		 843.1M 780.5M 726.4M 370.5M
    Long-Term Investments
    		 864.3M 849.4M 401.5M 624.4M
    Other Long-Term Assets
    		 15.5M 49.6M 25M 4.4M
    Receivables
    		 479.1M 439.3M 350M 185.5M
    Inventory
    		 57.4M 38.3M 35.1M 30.5M
    Other Current Assets
    		 112.1M 97.8M 79.1M 45.5M
    Total Current Assets
    		 1.72B 1.61B 1.45B 972.8M
    Property-Plant & Equipment
    		 592M 347.3M 145.6M 155.8M
    Goodwill & Intangibles
    		 36.5M 35.5M 37.2M n/a
    Total Long-Term Assets
    		 1.99B 1.64B 915.2M 1.1B
    Total Assets
    		 3.72B 3.25B 2.37B 2.07B
    Account Payables
    		 110M 133.3M 67.3M 51.5M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 170.1M 169.4M n/a
    Other Current Liabilities
    		 297.7M 261.4M 225.4M 133.3M
    Total Current Liabilities
    		 507.7M 654.8M 537.7M 245.8M
    Long-Term Debt
    		 n/a n/a n/a 335.1M
    Other Long-Term Liabilities
    		 166.2M 106.3M 29.7M 12.3M
    Total Long-Term Liabilities
    		 621.3M 364.6M 123.2M 452.7M
    Total Liabilities
    		 1.13B 1.02B 660.9M 698.5M
    Total Debt
    		 455.1M 428.4M 262.9M 440.4M
    Book Value
    		 2.59B 2.23B 1.71B 1.37B
    Book Value Per Share
    		 25.79 22.85 17.83 14.52
    Common Stock
    		 100K 100K 100K 100K
    Retained Earnings
    		 29.2M -157.1M -406.8M -635.8M
    Comprehensive Income
    		 5.8M 7M -7.9M -1.7M
    Shareholders Equity
    		 2.59B 2.23B 1.71B 1.37B
    Total Investments
    		 1.71B 1.63B 1.13B 994.9M

    Add to Watchlist